Acutus Medical concludes patient enrolment in AcQForce Flutter trial
The study enrolled a total of 110 patients at 21 sites.

The study enrolled a total of 110 patients at 21 sites.
Xpert Xpress CoV-2 plus is a rapid molecular diagnostic test designed to identify Covid-19 causing virus.
The technologies include SARS-CoV-2 stabilised spike protein, early-stage vaccine and diagnostic candidates, and research tools.
The company is currently working on a programme to develop tests for tropical diseases.
The company’s net income in the quarter jumped 51.7% Y-o-Y to $454m.
In the same quarter a year ago, the company reported revenues of $375.3m.
The company also reorganised its operations into two reportable segments during the quarter.
As cardiology departments around the world continue to emerge from Covid-19 and start to make headway on the huge backlog…